- Home
- Publications
- Publication Search
- Publication Details
Title
CD4 T-cell immunotherapy for chronic viral infections and cancer
Authors
Keywords
-
Journal
Immunotherapy
Volume 5, Issue 9, Pages 975-987
Publisher
Future Medicine Ltd
Online
2013-09-02
DOI
10.2217/imt.13.91
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- West Nile Virus-Specific CD4 T Cells Exhibit Direct Antiviral Cytokine Secretion and Cytotoxicity and Are Sufficient for Antiviral Protection
- (2014) J. D. Brien et al. JOURNAL OF IMMUNOLOGY
- Distinct Memory CD4+ T Cells with Commitment to T Follicular Helper- and T Helper 1-Cell Lineages Are Generated after Acute Viral Infection
- (2013) J. Scott Hale et al. IMMUNITY
- Inadequate T follicular cell help impairs B cell immunity during HIV infection
- (2013) Rafael A Cubas et al. NATURE MEDICINE
- Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
- (2013) James N. Kochenderfer et al. Nature Reviews Clinical Oncology
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- Germinal Centers
- (2012) Gabriel D. Victora et al. Annual Review of Immunology
- Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody
- (2012) E. J. Lipson et al. CLINICAL CANCER RESEARCH
- Expansion of HIV-specific T follicular helper cells in chronic HIV infection
- (2012) Madelene Lindqvist et al. JOURNAL OF CLINICAL INVESTIGATION
- CD4 T follicular helper cell dynamics during SIV infection
- (2012) Constantinos Petrovas et al. JOURNAL OF CLINICAL INVESTIGATION
- Dominance of the CD4+T helper cell response during acute resolving hepatitis A virus infection
- (2012) Yan Zhou et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Spatial Alterations between CD4+ T Follicular Helper, B, and CD8+ T Cells during Simian Immunodeficiency Virus Infection: T/B Cell Homeostasis, Activation, and Potential Mechanism for Viral Escape
- (2012) J. J. Hong et al. JOURNAL OF IMMUNOLOGY
- Multifunctional CD4 Cells Expressing Gamma Interferon and Perforin Mediate Protection against Lethal Influenza Virus Infection
- (2012) D. M. Brown et al. JOURNAL OF VIROLOGY
- HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
- (2012) Florian Klein et al. NATURE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Follicular Helper CD4 T Cells (TFH)
- (2011) Shane Crotty Annual Review of Immunology
- Responsiveness of HIV-specific CD4 T cells to PD-1 blockade
- (2011) F. Porichis et al. BLOOD
- B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
- (2011) J. N. Kochenderfer et al. BLOOD
- Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
- (2011) R. J. Brentjens et al. BLOOD
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy
- (2011) Cameron J Turtle et al. CURRENT OPINION IN IMMUNOLOGY
- How T Cells Earn the Follicular Rite of Passage
- (2011) Carola G. Vinuesa et al. IMMUNITY
- Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells
- (2011) Laura M. Fahey et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection
- (2011) Charlly Kao et al. NATURE IMMUNOLOGY
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection
- (2011) Noah S Butler et al. NATURE IMMUNOLOGY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection
- (2011) R. D. Aubert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Late Interleukin-6 Escalates T Follicular Helper Cell Responses and Controls a Chronic Viral Infection
- (2011) J. A. Harker et al. SCIENCE
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Engineering HIV-Resistant Human CD4+ T Cells with CXCR4-Specific Zinc-Finger Nucleases
- (2011) Craig B. Wilen et al. PLoS Pathogens
- Germinal Center Dynamics Revealed by Multiphoton Microscopy with a Photoactivatable Fluorescent Reporter
- (2010) Gabriel D. Victora et al. CELL
- Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy
- (2010) Deborah M. Brown CELLULAR IMMUNOLOGY
- HIV-1-Specific Interleukin-21+ CD4+ T Cell Responses Contribute to Durable Viral Control through the Modulation of HIV-Specific CD8+ T Cell Function
- (2010) M. F. Chevalier et al. JOURNAL OF VIROLOGY
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
- (2009) H. E. Heslop et al. BLOOD
- Redefining Chronic Viral Infection
- (2009) Herbert W. Virgin et al. CELL
- Adoptive immunotherapy of cancer using CD4+ T cells
- (2009) Pawel Muranski et al. CURRENT OPINION IN IMMUNOLOGY
- CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell help
- (2009) Yusuke Nakanishi et al. NATURE
- Cytokine-secreting follicular T cells shape the antibody repertoire
- (2009) R Lee Reinhardt et al. NATURE IMMUNOLOGY
- Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy
- (2009) F. R. Depontieu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Vital Role for Interleukin-21 in the Control of a Chronic Viral Infection
- (2009) J. S. Yi et al. SCIENCE
- IL-21 Is Required to Control Chronic Viral Infection
- (2009) H. Elsaesser et al. SCIENCE
- IL-21R on T Cells Is Critical for Sustained Functionality and Control of Chronic Viral Infection
- (2009) A. Frohlich et al. SCIENCE
- Impaired Antibody Response Causes Persistence of Prototypic T Cell–Contained Virus
- (2009) Andreas Bergthaler et al. PLOS BIOLOGY
- PD-1 Expression and IL-2 Loss of Cytomegalovirus- Specific T Cells Correlates with Viremia and Reversible Functional Anergy
- (2008) U. Sester et al. AMERICAN JOURNAL OF TRANSPLANTATION
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Homeostasis of Naive and Memory T Cells
- (2008) Charles D. Surh et al. IMMUNITY
- Adoptive immunotherapy: good habits instilled at youth have long-term benefits
- (2008) Chrystal M. Paulos et al. IMMUNOLOGIC RESEARCH
- Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
- (2008) Carolina Berger et al. JOURNAL OF CLINICAL INVESTIGATION
- Enhancing SIV-specific immunity in vivo by PD-1 blockade
- (2008) Vijayakumar Velu et al. NATURE
- Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
- (2008) Elena E Perez et al. NATURE BIOTECHNOLOGY
- Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
- (2008) Naomi N. Hunder et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started